Adjuvant Everolimus Falls Short in High-Risk Kidney Cancer
However, the drug did show benefit in a subgroup at highest risk of recurrence after nephrectomy
Source: medpagetoday.com
Jens Bedke News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Jens Bedke. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Jens Bedke Today - Breaking & Trending Today
Immunotherapy Combos Up Survival in Renal Cell Carcinoma
In the absence of head-to-head trials, the findings help validate the applicability of phase 3 results to routine care. The study was published as a preprint and has not yet been peer reviewed.
Source: medscape.com